東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/10/23 | 2,018 | 2,020 | 1,976 | 1,980 | -20 | -1% | 83,000 |
2020/10/22 | 2,029 | 2,029 | 2,000 | 2,000 | -46 | -2.2% | 44,300 |
2020/10/21 | 2,025 | 2,050 | 2,010 | 2,046 | +20 | +1% | 87,600 |
2020/10/20 | 2,030 | 2,053 | 2,022 | 2,026 | +9 | +0.4% | 107,800 |
2020/10/19 | 1,995 | 2,044 | 1,995 | 2,017 | +51 | +2.6% | 108,300 |
2020/10/16 | 1,980 | 1,985 | 1,965 | 1,966 | +1 | +0.1% | 75,000 |
2020/10/15 | 1,981 | 2,005 | 1,958 | 1,965 | -25 | -1.3% | 64,400 |
2020/10/14 | 2,004 | 2,034 | 1,988 | 1,990 | -28 | -1.4% | 97,800 |
2020/10/13 | 2,028 | 2,031 | 2,003 | 2,018 | -21 | -1% | 62,400 |
2020/10/12 | 2,024 | 2,056 | 2,017 | 2,039 | +11 | +0.5% | 70,400 |
2020/10/09 | 2,030 | 2,058 | 2,017 | 2,028 | -2 | -0.1% | 103,900 |
2020/10/08 | 2,035 | 2,044 | 2,005 | 2,030 | +3 | +0.1% | 97,300 |
2020/10/07 | 2,045 | 2,058 | 2,023 | 2,027 | -26 | -1.3% | 62,500 |
2020/10/06 | 2,070 | 2,077 | 2,035 | 2,053 | -15 | -0.7% | 100,000 |
2020/10/05 | 2,060 | 2,119 | 2,060 | 2,068 | +31 | +1.5% | 66,200 |
2020/10/02 | 2,109 | 2,124 | 2,028 | 2,037 | - | - | 113,900 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 2,157 | 2,157 | 2,109 | 2,109 | -52 | -2.4% | 90,600 |
2020/09/29 | 2,200 | 2,200 | 2,128 | 2,161 | -69 | -3.1% | 90,700 |
2020/09/28 | 2,200 | 2,235 | 2,182 | 2,230 | +48 | +2.2% | 114,300 |
2020/09/25 | 2,220 | 2,225 | 2,160 | 2,182 | +4 | +0.2% | 129,300 |
2020/09/24 | 2,190 | 2,214 | 2,176 | 2,178 | -18 | -0.8% | 76,600 |
2020/09/23 | 2,187 | 2,206 | 2,169 | 2,196 | ±0 | ±0% | 128,500 |
2020/09/18 | 2,185 | 2,207 | 2,181 | 2,196 | +11 | +0.5% | 105,200 |
2020/09/17 | 2,184 | 2,195 | 2,164 | 2,185 | +14 | +0.6% | 64,200 |
2020/09/16 | 2,160 | 2,193 | 2,158 | 2,171 | -3 | -0.1% | 76,200 |
2020/09/15 | 2,191 | 2,193 | 2,163 | 2,174 | -4 | -0.2% | 93,800 |
2020/09/14 | 2,136 | 2,188 | 2,130 | 2,178 | +62 | +2.9% | 109,900 |
2020/09/11 | 2,091 | 2,117 | 2,061 | 2,116 | -4 | -0.2% | 113,000 |
2020/09/10 | 2,124 | 2,147 | 2,104 | 2,120 | +17 | +0.8% | 109,600 |
2020/09/09 | 2,088 | 2,114 | 2,081 | 2,103 | -18 | -0.8% | 75,100 |
2020/09/08 | 2,081 | 2,125 | 2,078 | 2,121 | +59 | +2.9% | 91,100 |
2020/09/07 | 2,042 | 2,075 | 2,042 | 2,062 | +22 | +1.1% | 59,400 |
2020/09/04 | 2,048 | 2,060 | 2,021 | 2,040 | -40 | -1.9% | 63,000 |
2020/09/03 | 2,124 | 2,124 | 2,073 | 2,080 | -19 | -0.9% | 47,700 |
2020/09/02 | 2,088 | 2,100 | 2,070 | 2,099 | +12 | +0.6% | 48,300 |
2020/09/01 | 2,100 | 2,101 | 2,073 | 2,087 | -15 | -0.7% | 54,900 |
2020/08/31 | 2,115 | 2,139 | 2,093 | 2,102 | -21 | -1% | 128,300 |
2020/08/28 | 2,147 | 2,172 | 2,091 | 2,123 | -24 | -1.1% | 124,600 |
2020/08/27 | 2,175 | 2,175 | 2,136 | 2,147 | -29 | -1.3% | 74,900 |
2020/08/26 | 2,171 | 2,183 | 2,147 | 2,176 | +2 | +0.1% | 43,400 |
2020/08/25 | 2,205 | 2,208 | 2,161 | 2,174 | +5 | +0.2% | 80,000 |
2020/08/24 | 2,191 | 2,191 | 2,156 | 2,169 | -24 | -1.1% | 39,400 |
2020/08/21 | 2,162 | 2,203 | 2,158 | 2,193 | +31 | +1.4% | 105,600 |
2020/08/20 | 2,159 | 2,188 | 2,146 | 2,162 | -8 | -0.4% | 89,200 |
2020/08/19 | 2,156 | 2,176 | 2,145 | 2,170 | +25 | +1.2% | 89,300 |
2020/08/18 | 2,124 | 2,152 | 2,115 | 2,145 | +11 | +0.5% | 84,200 |
2020/08/17 | 2,159 | 2,168 | 2,122 | 2,134 | -1 | ±0% | 103,500 |
2020/08/14 | 2,094 | 2,183 | 2,082 | 2,135 | +83 | +4% | 291,900 |
2020/08/13 | 2,039 | 2,068 | 2,030 | 2,052 | +26 | +1.3% | 131,600 |
1001~
1050
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム